おすすめの製品
詳細
specificity:GM6001 MMP inhibitor, also known as Ilomastat or N-[(2R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl]-L-tryptophan methylamide, is a potent inhibitor of collagenases. Molecular weight: 388.47
Reported Ki values are as follows (see Galardy Ref):
Human MMP-1 (Fibroblast collagenase): 0.4 nM
Human MMP-3 (Stromelysin): 27 nM
Human MMP-2 (72 kDa gelatinase): 0.5 nM
Human MMP-8 (Neutrophil collagenase): 0.1 nM
Human MMP-9 (92 kDa gelatinase): 0.2 nM
Typical working dilution for use in cultured cells is 10-25 μM. {1mg/ml solution in DMSO equals 2.57 mM}. GM6001 will precipitate from aqueous solutions exceeding 100μM. Aqueous dilutions should be performed using low salt buffers to prevent precipitation of GM6001 from solution (Recommended dilution buffer: 50 mM Tris pH7.5, 150 mM NaCl, and 20 mM CaCl2.2H20). It is recommended that the concentration of GM6001 in aqueous working solutions is determined upon dilution and confirmed prior to each use. Additional Application information:
Use in vivo
Typical dosage for GM6001 in animals is 50-100mg/kg body weight. It is generally administered IP every day or every other day. It is thought to cross the blood brain barrier since studies have shown it effectiveness in MS models.
If delivered by I.V. the half life in an animal is approximate an hour so it will have to be administered quite often. Thus the preferred way is to deliver the drug by I.P as a suspension in water or saline. The half life does not change but because it is dissolving in the animal′s system slowly, administration is not done as frequently. It has to be redelivered every other day or so. It can also be delivered subcutaneously in a saline suspension. The drug will precipitate as stay as a mass within the tissue, but surprisingly enough does get into the animal system to be effective.
Solubility
Soluble up to at least 400 mg/mL in DMSO. It can then be diluted in water and must be mixed very quickly to avoid precipitation.
Stability
At a concentration of 1mM (0.1mM is preferred), GM6001 decomposes at the rate of 1% per month at 4°C. At 37°C this increases to 1% per day. At -20°C it is quite stable, and as a solid very highly stable
Low salt buffers are recommended as diluents to reduce precipitation. Diluted solutions should never be frozen.
Concentration of the stock solution should be periodically determined by absorbance at 280 nm.
Reported Ki values are as follows (see Galardy Ref):
Human MMP-1 (Fibroblast collagenase): 0.4 nM
Human MMP-3 (Stromelysin): 27 nM
Human MMP-2 (72 kDa gelatinase): 0.5 nM
Human MMP-8 (Neutrophil collagenase): 0.1 nM
Human MMP-9 (92 kDa gelatinase): 0.2 nM
Typical working dilution for use in cultured cells is 10-25 μM. {1mg/ml solution in DMSO equals 2.57 mM}. GM6001 will precipitate from aqueous solutions exceeding 100μM. Aqueous dilutions should be performed using low salt buffers to prevent precipitation of GM6001 from solution (Recommended dilution buffer: 50 mM Tris pH7.5, 150 mM NaCl, and 20 mM CaCl2.2H20). It is recommended that the concentration of GM6001 in aqueous working solutions is determined upon dilution and confirmed prior to each use. Additional Application information:
Use in vivo
Typical dosage for GM6001 in animals is 50-100mg/kg body weight. It is generally administered IP every day or every other day. It is thought to cross the blood brain barrier since studies have shown it effectiveness in MS models.
If delivered by I.V. the half life in an animal is approximate an hour so it will have to be administered quite often. Thus the preferred way is to deliver the drug by I.P as a suspension in water or saline. The half life does not change but because it is dissolving in the animal′s system slowly, administration is not done as frequently. It has to be redelivered every other day or so. It can also be delivered subcutaneously in a saline suspension. The drug will precipitate as stay as a mass within the tissue, but surprisingly enough does get into the animal system to be effective.
Solubility
Soluble up to at least 400 mg/mL in DMSO. It can then be diluted in water and must be mixed very quickly to avoid precipitation.
Stability
At a concentration of 1mM (0.1mM is preferred), GM6001 decomposes at the rate of 1% per month at 4°C. At 37°C this increases to 1% per day. At -20°C it is quite stable, and as a solid very highly stable
Low salt buffers are recommended as diluents to reduce precipitation. Diluted solutions should never be frozen.
Concentration of the stock solution should be periodically determined by absorbance at 280 nm.
アプリケーション
The GM6001 MMP Inhibitor Powder controls the biological activity of MMP. This small molecule/inhibitor is primarily used for Biochemicals applications.
生物化学的/生理学的作用
Protein Target: Interstitial collagenase
Inhibitor Type: Protease Inhibitors
物理的形状
Lyophilized, reconstitute in DMSO (1-5 mg/ml). Other organic solvents (ethanol) have also been used (Galardy et al., 1994).
some batches can be brown when hydrated; brown color does not influence inhibition ability; in solution GM6001 ranges from clear to brown
保管および安定性
Maintain lyophilized form at 2-8º C for up to one year from date of receipt. If reconstitution is in DMSO, material is soluble to at least 400 mg/mL and storage is recommended in usable aliquots at -20 º C. Avoid repeated freeze/thaw cycles. If reconstituting in aqueous solution, store short term in undiluted aliquots at 2-8º C. See stability information for further detail.
法的情報
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
免責事項
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
保管分類コード
11 - Combustible Solids
WGK
WGK 3
引火点(°F)
Not applicable
引火点(℃)
Not applicable
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
Jan Code
CC1100:
試験成績書(COA)
製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。
Breast cancer research and treatment, 94(2), 185-193 (2005-09-06)
Tissue inhibitor of metalloproteinases-1 (TIMP-1) is a widely expressed, secreted protein that functions primarily to inhibit members of a large family of metalloproteinases (MPs). Because of the ability of TIMP-1 to inhibit MPs, it functions in many of the same
Journal of medicinal chemistry, 41(2), 199-223 (1998-02-11)
Modifications around the dipeptide-mimetic core of a hydroxamic acid based matrix metalloproteinase inhibitor were studied. These variations incorporated a variety of natural, unnatural, and synthetic amino acids in addition to modifications of the P1' and P3' substituents. The results of
Developmental biology, 261(2), 313-323 (2003-09-23)
Tissue inhibitors of metalloproteinases (TIMPs) regulate extracellular matrix (ECM) degradation by matrix metalloproteinases (MMPs). We have examined the role of TIMP-3 on ECM homeostasis and bronchiole branching morphogenesis during murine embryogenesis. Employing an in vitro organ culture system, we found
Low molecular weight inhibitors in corneal ulceration.
Annals of the New York Academy of Sciences, 732, 315-323 (1994-09-06)
Nature biotechnology, 21(5), 513-518 (2003-04-22)
We have engineered synthetic poly(ethylene glycol) (PEG)-based hydrogels as cell-ingrowth matrices for in situ bone regeneration. These networks contain a combination of pendant oligopeptide ligands for cell adhesion (RGDSP) and substrates for matrix metalloproteinase (MMP) as linkers between PEG chains.
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら(テクニカルサービス)